Ron A. A. Mathôt

11.3k citations

317 papers · 8.1k indexed · 1 hit paper · h-index 45

Impact in

Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments
Physiology top 0.5%
- Adenosine and Purinergic Signaling

Papers in

Transplantation 26
- Renal Transplantation Outcomes and Treatments 26
Hematology 59
- Hemophilia Treatment and Research 44
- Platelet Disorders and Treatments 33

Co-authors: Teun van Gelder Reinier M. van Hest Dick Tibboel Geert D’Haens Jaap Verweij Mark Löwenberg Maurice J. Ahsman Arnold G. Vulto
Journals: Therapeutic Drug Monitoring (28 papers)British Journal of Clinical Pharmacology (23 papers)Clinical Pharmacokinetics (12 papers)Antimicrobial Agents and Chemotherapy (10 papers)Thrombosis and Haemostasis (9 papers)
Partner nations: Netherlands United States Belgium

In The Last Decade

Ron A. A. Mathôt

304 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis 2015 · 304 citations

Peers

Countries citing papers authored by Ron A. A. Mathôt

Since Specialization

Citations

This map shows the geographic impact of Ron A. A. Mathôt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron A. A. Mathôt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron A. A. Mathôt more than expected).

Fields of papers citing papers by Ron A. A. Mathôt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron A. A. Mathôt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron A. A. Mathôt. The network helps show where Ron A. A. Mathôt may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ron A. A. Mathôt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ron A. A. Mathôt Line = papers co-authored together Ron A. A. Mathôt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	DOP017 Infliximab induction fails to reach targets in Perianal Fistulizing Crohn’s Disease: first results from the ATLANTIC study Journal of Crohn s and Colitis ·Susan E. Smith, Amy Lee Richards, M Chevallot-Beroux, Xing Yiyang, Ron A. A. Mathôt, Geert D’Haens, K Gecse	2025	0
2	Smaller nadroparin dose reductions required for patients with renal impairment: A multicenter cohort study Thrombosis Research ·Samin Riazi, Claudia Ayyildiz, Karina Meijer, Karlijn J. van Stralen, Barbara Maat, Nakisa Khorsand, Hein A. W. van Onzenoort, Eleonora L. Swart, U. Stuhr, Ron A. A. Mathôt, Michaël V. Lukens, Patricia M. L. A. van den Bemt, Matthijs L. Becker	2024	1
3	PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space CPT Pharmacometrics & Systems Pharmacology ·Т.Ф. Тумаров, Erik Sjögren, Sarahbeth Purcell, Peter J. Lenting, Marjon H. Cnossen, Ron A. A. Mathôt	2024	1
4	Peri‐operative desmopressin combined with pharmacokinetic‐guided factor VIII concentrate in non‐severe haemophilia A patients Haemophilia ·Sheeba Sagar, Bian'an Zhu, Reinier M. van Hest, Karina Meijer, Britta A. P. Laros‐van Gorkom, Laurens Nieuwenhuizen, Jeroen Eikenboom, Floor Heubel-Moenen, Dagmar Ellerbrock, Michiel Coppens, Karin Fijnvandraat, M.H.E. Driessens, Suzanne Polinder, Marjon H. Cnossen, Frank W.G. Leebeek, Ron A. A. Mathôt, Marieke J. H. A. Kruip	2024	0
5	Benzylpenicillin concentrations in umbilical cord blood and plasma of premature neonates following intrapartum doses for group B streptococcal prophylaxis SHILAP Revista de lepidopterología ·James E. Foehl, Smit Jh, Yuma A. Bijleveld, Timo R. de Haan, Caspar J. Hodiamont, Elisabeth van Leeuwen, A.H.L.C. van Kaam, Ron A. A. Mathôt, Douwe H. Visser	2023	0
6	A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B British Journal of Clinical Pharmacology ·Sarahbeth Purcell, J Klimcík, 金汝平, B. Strusievici, Frank W.G. Leebeek, Karin Fijnvandraat, Michiel Coppens, Mary Mathias, Peter W. Collins, Robert C. Tait, Catherine Bagot, Nicola Curry, Jeanette Payne, Pratima Chowdary, Marjon H. Cnossen, Ron A. A. Mathôt	2023	3
7	DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A BMJ Open ·pMiriam Sanchez Reyesp, 飯田ひろし, Toine C. G. Egberts, Karin Fijnvandraat, Ron A. A. Mathôt, Juan Marti Masias, Marjon H. Cnossen, Roger E. G. Schutgens, Rolf T. Urbanus, Kathelijn Fischer	2023	3
8	Therapeutic drug monitoring of amikacin in preterm and term neonates with late‐onset sepsis. Can saliva samples replace plasma samples? British Journal of Clinical Pharmacology ·James E. Foehl, June Sutherland, Yuma A. Bijleveld, Anton van Kaam, Timo R. de Haan, Ron A. A. Mathôt	2023	2
9	ChatGPT in pharmacometrics? Potential opportunities and limitations British Journal of Clinical Pharmacology ·Т.Ф. Тумаров, Alexander Janßen, Sarahbeth Purcell, Marjon H. Cnossen, Ron A. A. Mathôt	2023	17
10	Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic–Pharmacodynamic Modeling Journal of Investigative Dermatology ·Y‐H Tai, Teraze A. Youssef, G. E. van der Kraaij, Annelie H. Musters, Stacy Scofield- Kaplan, S.P. Menting, Theo Rispens, Annick de Vries, Martijn B. A. van Doorn, Errol P. Prens, Jo Lambert, J. M. P. A. van den Reek, E.M.G.J. de Jong, Ron A. A. Mathôt, Phyllis I. Spuls	2023	3
11	Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies Journal of Antimicrobial Chemotherapy ·И. Л. Ионкин, Tazzoli, Reinier M. van Hest, Paul D. van der Linden, Sanne H. Tonino, Luis Felipe Castelli Correia de Campos, Ron A. A. Mathôt, Nicole M. A. Blijlevens, Catherijne A. J. Knibbe, Roger J. M. Brüggemann, Suzanne E. Geerlings	2022	1
12	Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial Journal of Dermatological Treatment ·M Babjuk, Sophie E. Berends, Hans Groenewoud, Ron A. A. Mathôt, José Jesús Geraldo Corralejo, J.M. Mommers, Paul M. Ossenkoppele, M.I.A. Koetsier, M.A.M. Berends, Annick de Vries, P.C.M. van de Kerkhof, Alfons A den Broeder, E.M.G.J. de Jong, J. M. P. A. van den Reek	2022	8
13	Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children Journal of Antimicrobial Chemotherapy ·三島秀晶, آزاده حاجی حسنی, Ron A. A. Mathôt, Michiel van der Flier, Michiel F. Schreuder, Roger J. M. Brüggemann, Catherijne A. J. Knibbe, Saskia N. de Wildt	2022	3
14	von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A Patients Thrombosis and Haemostasis ·Bruno Fattori, 金汝平, Enric Rovira Canellas, Roger E. G. Schutgens, Britta A. P. Laros‐van Gorkom, Laurens Nieuwenhuizen, F.J.M. van der Meer, Karin Fijnvandraat, Paula F. Ypma, Moniek P.M. de Maat, Frank W.G. Leebeek, Karina Meijer, Jeroen Eikenboom, Ron A. A. Mathôt, Marjon H. Cnossen, (unknown)	2020	5
15	Pharmacokinetics and population pharmacokinetics in pediatric oncology Pediatric Blood & Cancer ·Nicole Ó Catháin, C. Michel Zwaan, Inge M. van der Sluis, Ron A. A. Mathôt	2019	6
16	Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients Clinical Infectious Diseases ·Nicole Ó Catháin, Ron A. A. Mathôt, Rob Pieters, Válerie de Haas, Gertjan J.L. Kaspers, Cor van den Bos, Wim J. E. Tissing, D. Maroeska W. M. te Loo, Marc Bierings, Mireille van Westreenen, Inge M. van der Sluis, C. Michel Zwaan	2019	5
17	Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study Thrombosis Research ·Y. Whitney Cheung, Stefano Barco, Ron A. A. Mathôt, Marian Oczachowski, An K. Stroobants, Mireille J. Serlie, Saskia Middeldorp, Michiel Coppens	2017	15
18	Pharmacokinetics of S‐ketamine during prolonged sedation at the pediatric intensive care unit Pediatric Anesthesia ·Robert B. Flint, Carole N. M. Brouwer, Von Rainer, Loraine Lie‐A‐Huen, Albert P. Bos, Ron A. A. Mathôt	2017	13
19	Acute liver failure after recommended doses of acetaminophen in patients with myopathies Critical Care Medicine ·Ilse Ceelie, Laura P. James, Violette Gijsen, Ron A. A. Mathôt, Shinya Ito, A. P. Rafferty, Dick Tibboel, Gideon Koren, Saskia N. de Wildt	2011	15
20	Influence of medicinal cannabis (MC) on the pharmacokinetics (PK) of docetaxel (DOC) and irinotecan (CPT-11) Cancer Research ·Floris A. de Jong, Barbara Owcorz-Cydzik, Alex Sparreboom, Walter J. Loos, Peter de Bruijn, Lena E. Friberg, Ron A. A. Mathôt, Jaap Verweij, Ron H.J. Mathijssen	2005	5

About Ron A. A. Mathôt

Ron A. A. Mathôt is a scholar working on Transplantation, Hematology, Physiology, Anesthesiology and Pain Medicine and Pharmacology, having authored 317 papers that have together received 8.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (48 papers), Hemophilia Treatment and Research (44 papers), Platelet Disorders and Treatments (33 papers), Pharmacogenetics and Drug Metabolism (27 papers), Inflammatory Bowel Disease (27 papers), Renal Transplantation Outcomes and Treatments (26 papers), Pharmacological Effects and Toxicity Studies (25 papers) and Microscopic Colitis (25 papers). The work is most often cited by research in Transplantation (1.3k citations), Physiology (379 citations), Pharmacology (1.3k citations), Pharmacology (659 citations) and Pediatrics, Perinatology and Child Health (1.4k citations). Ron A. A. Mathôt has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Teun van Gelder, Reinier M. van Hest, Dick Tibboel, Geert D’Haens, Jaap Verweij, Mark Löwenberg, Maurice J. Ahsman, Arnold G. Vulto, Jos H. Beijnen and Enno D. Wildschut. Their work appears in journals such as Therapeutic Drug Monitoring, British Journal of Clinical Pharmacology, Clinical Pharmacokinetics, Antimicrobial Agents and Chemotherapy and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact